Missionpharma expects to reach a billion within five years
Owner and chairman of the board in Missionpharma, Kim Ginnerup, wants to double company turnover over the next five years. But the largest investments are to be made outside of Denmark.
af KRESTEN MORTEN MUNKSGAARD
Growth markets, moving the company abroad and focusing on new business areas will help double turnover in the Danish pharmaceutical wholesale company Missionpharma within five years, explains chairman of the board and owner of the Danish company in an interview with Medwatch.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
